http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-0165920-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7463de9996296080aee425ed480146b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 |
| filingDate | 1995-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03d92e1ffe22b94565c70cbc361a1967 |
| publicationDate | 1999-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-0165920-B1 |
| titleOfInvention | How to prepare triple tablets |
| abstract | The present invention relates to a method for preparing a gastrointestinal drug in the form of a triple tablet, wherein the upper layer and the lower layer are mixed, granulated, and mixed with antacid sodium bicarbonate, magnesium metasilicate aluminate, magnesium carbonate and aldioxa (allantoin). In the middle layer, biodiastatase, lipase, and scopolyax were mixed in the middle layer and compressed into three tablets. The upper layer and the lower layer maintain the pH of the enzyme by 3.5 ~ 5.0 for gastric hashing. A novel triplet gastrointestinal drug characterized by maximizing. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100467146-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100467147-B1 |
| priorityDate | 1995-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 101.